NYSE · LLY
Eli Lilly and Company
$1,417.54+$43.84 (+3.19%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.22% below the high.
Loading market information…
OTC · VTEQ · USD
Stock price
Quote as of Dec 16, 2022, 05:04 PM UTC. Cached market data; not a live quote.
Price history is currently unavailable.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Established in 1995 and based in Boca Raton, Florida, VeriTeQ Corporation operates an e-commerce platform specializing in orthopedic braces and various physical therapy and rehabilitation equipment. Their extensive selection of braces addresses needs for areas such as the knee, ankle, back, wrist, shoulder, elbow, foot, and neck. Additionally, the company provides products like hot and cold therapy solutions, electrical stimulation devices, medical tables, and ambulatory aids. VeriTeQ distributes its offerings not only through its website but also to a range of institutional clients, including healthcare professionals, hospitals, clinics, government entities, and school sports teams.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:44 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$1,417.54+$43.84 (+3.19%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.22% below the high.
$273.20-$2.00 (-0.73%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 3.12% below the high.
$294.89+$4.10 (+1.41%)
AbbVie Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.29% below the high.
$149.52+$3.19 (+2.18%)
Merck & Co., Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.72% below the high.
$406.97-$3.94 (-0.96%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 11.84% below the high.
$697.00-$12.18 (-1.72%)
Thermo Fisher Scientific Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.09% below the high.
$466.01+$5.28 (+1.15%)
Amgen Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.03% below the high.
$170.68+$5.07 (+3.06%)
Gilead Sciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.83% below the high.
